// company-profile

Acumen Pharmaceuticals, Inc.

ABOS
ExchangeNasdaqSectorBiological Products, (No Diagnostic Substances)Inc.DEFilings85Insiders19
// api This Acumen Pharmaceuticals, Inc. insider-trading data is served live by the Form4API insider trading API. Get the same data via API.

// activity-summary

Recent insider activity is bullish. Over the last 30 days, 20 insiders purchased shares versus 4 sales. Buying was led by Porter Derrell.

// 90-day insight

Over the last 90 days, Acumen Pharmaceuticals, Inc. insiders bought $21K (20 transactions) and sold $90K (4 transactions).

  • Most active insider: Porter Derrell with 9 transactions totaling $96K.
  • Largest single sale: $30K by Porter Derrell on Jun 17, 2026.

Activity skews bullish — buys outpace sales.

Institutional Ownership

Top 13F-HR holders of Acumen Pharmaceuticals, Inc. as of 2026-03-31

↑ increasing
Total reported AUM
$106.2M
QoQ change
+43.9%
Reporting period
2026-03-31
#1
RA CAPITAL MANAGEMENT, L.P.
CIK 1346824
$49.5M
21.0M shares
#2
Sands Capital Alternatives, LLC
CIK 1846444
$8.8M
3.7M shares
#3
Alyeska Investment Group, L.P.
CIK 1453072
$5.8M
2.5M shares

Data source: SEC Form 13F-HR filings. Joined with insider activity above — see who's loading up institutionally while insiders are trading. Full 13F-HR API →

Insider Transactions

Sourced from SEC EDGAR Form 4 filings. Updated hourly.

DateInsiderCompanyTypeSharesPriceValue
Jun 17, 2026Porter DerrellABOS
Sale
13,040$2.33$30K
Jun 17, 2026Porter DerrellABOS
Option Exercise
13,040$1.07$14K
Jun 17, 2026Porter DerrellABOS
Option Exercise
13,040$0.00$0K
Jun 16, 2026Porter DerrellABOS
Sale
12,800$2.33$30K
Jun 15, 2026Porter DerrellABOS
Sale
6,460$2.35$15K

45 more transactions hidden

Free account · No credit card required

Building something? Get API access →

Popular companies on Form4API

Browse insider trading activity for other actively-filed companies.